Cutaneous Polyarteritis Nodosa in Childhood: A Case Report and Review of the Literature

Table 2

Frequency of therapies used in management of childhood cPAN (𝑁=112).

Medication∗	𝑁 (%)	References
Corticosteroid	96 (85.7)	[4, 5, 7–14, 16, 21, 22, 24–35, 39–41, 43–51, 53]
DMARD (azathioprine, cyclophosphamide, methotrexate, and mycophenolate mofetil)	37 (33)	[4, 5, 8, 10–12, 15, 21, 22, 29, 30, 34, 37, 45, 47–50, 53]
Penicillin	33 (29.5)	[7, 9, 11, 13, 14, 16, 24, 37, 41, 42, 44, 46, 47]
ASA	12 (10.7)	[9, 14, 24, 29, 31–33, 38, 42, 45]
NSAID	12 (10.7)	[4, 9, 11, 16, 24, 26, 28, 31, 32, 37, 41]
IVIG	11 (9.8)	[9, 11, 14, 15, 35, 36, 42, 45, 51, 53]
Biologic (infliximab, etanercept)	2 (1.8)	[3]
Other (colchicine, dapsone, oxpentifylline, ACTH, and platonin)	12 (10.7)	[8, 13, 18, 29, 53]

∗Used at anytime throughout disease management